
Current phase 3 studies investigative novel, preventative approaches.
Investigational oral MET kinase inhibitor from Merck.
The age indication for some influenza vaccines has been expanded.
New changes are making it more difficult for generics and biosimilars to compete on formularies.
Technicians, clerks, even front-end cashiers are taking on new responsibilities.
Oral supplements for metabolic disorder.
Oral kinase inhibitor for SSc-ILD.
First generic specialty injections approved for Novadoz Pharmaceuticals.
We need to stand up for anywhere our profession has a profound impact on healthcare, writes Kreckel.
Prescriptions for COPD contribute to antimicrobial resistance.
Texas pharmacies worked with “runners” to divert prescription opioids to the streets.
New concept offers dental, lab tests, immunizations, and other services.
Number of reported cases hightest since 1992.
Technology will help connect and engage with younger customers.
Though decreasing, initiatives and awareness will generate more revenue.
Rare instances of worsening liver function reported to FDA.
New results contradict HHS and FDA plans.
Cariprazine demonstrated greater improvement on the MADRS.
Grant-funded program to bring more opportunities for safe disposal.
A cure and a bargain?
Good Neighbor Pharmacy, Sam’s Club receive top rankings.
Pharmacists must continue to minimize the convenience gap between physician and pharmacy.